Therapeutic potential of the target on NLRP3 inflammasome in multiple sclerosis
S Shao, C Chen, G Shi, Y Zhou, Y Wei, N Fan… - Pharmacology & …, 2021 - Elsevier
Inflammasomes are multi-protein macromolecular complexes that typically comprise of three
units, a sensor, an adaptor and procaspase-1. The assembly of each inflammasome is …
units, a sensor, an adaptor and procaspase-1. The assembly of each inflammasome is …
Focus on the role of the NLRP3 inflammasome in multiple sclerosis: pathogenesis, diagnosis, and therapeutics
Y Cui, H Yu, Z Bu, L Wen, L Yan, J Feng - Frontiers in Molecular …, 2022 - frontiersin.org
Neuroinflammation is initiated with an aberrant innate immune response in the central
nervous system (CNS) and is involved in many neurological diseases. Inflammasomes are …
nervous system (CNS) and is involved in many neurological diseases. Inflammasomes are …
The roles of the NLRP3 inflammasome in neurodegenerative and metabolic diseases and in relevant advanced therapeutic interventions
Inflammasomes are intracellular multiprotein complexes in the cytoplasm that regulate
inflammation activation in the innate immune system in response to pathogens and to host …
inflammation activation in the innate immune system in response to pathogens and to host …
Therapeutic regulation of the NLRP3 inflammasome in chronic inflammatory diseases
Inflammasomes are cytosolic pattern recognition receptors that recognize pathogen-
associated molecular patterns (PAMPs) and danger-associated molecular patterns (DAMPs) …
associated molecular patterns (PAMPs) and danger-associated molecular patterns (DAMPs) …
Microglial NLRP3 inflammasome activation in multiple sclerosis
Multiple sclerosis (MS) is a chronic, autoimmune and neuroinflammatory disease of the
central nervous system (CNS) mediated by autoreactive T cells directed against myelin …
central nervous system (CNS) mediated by autoreactive T cells directed against myelin …
NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients
S Malhotra, C Costa, H Eixarch, CW Keller, L Amman… - Brain, 2020 - academic.oup.com
Primary progressive multiple sclerosis is a poorly understood disease entity with no specific
prognostic biomarkers and scarce therapeutic options. We aimed to identify disease activity …
prognostic biomarkers and scarce therapeutic options. We aimed to identify disease activity …
The NLRP3 inflammasome in health and disease: the good, the bad and the ugly
P Menu, JE Vince - Clinical & Experimental Immunology, 2011 - academic.oup.com
Summary While interleukin (IL)-1β plays an important role in combating the invading
pathogen as part of the innate immune response, its dysregulation is responsible for a …
pathogen as part of the innate immune response, its dysregulation is responsible for a …
The NLRP3 inflammasome: a new player in neurological diseases
Inflammasomes are supramolecular protein complexes implicated in the detection of
pathogens or danger-associated molecules and are responsible for mounting the first line of …
pathogens or danger-associated molecules and are responsible for mounting the first line of …
[HTML][HTML] The involvement of NLRP3 inflammasome in the treatment of neurodegenerative diseases
YS Feng, ZX Tan, LY Wu, F Dong, F Zhang - Biomedicine & …, 2021 - Elsevier
In an ageing society, neurodegenerative diseases have attracted attention because of their
high incidence worldwide. Despite extensive research, there is a lack of conclusive insights …
high incidence worldwide. Despite extensive research, there is a lack of conclusive insights …
Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives
The inflammasome is a molecular platform formed by activation of an innate immune pattern
recognition receptor seed, such as NLRP3. Once activated, NLRP3 recruits the adapter ASC …
recognition receptor seed, such as NLRP3. Once activated, NLRP3 recruits the adapter ASC …
相关搜索
- therapeutic target nlrp3 inflammasome
- sclerosis patients nlrp3 inflammasome
- therapeutic target sclerosis patients
- neurological diseases nlrp3 inflammasome
- prognostic factor nlrp3 inflammasome
- therapeutic target prognostic factor
- therapeutic potential nlrp3 inflammasome
- therapeutic regulation nlrp3 inflammasome
- neurodegenerative diseases nlrp3 inflammasome
- health and disease nlrp3 inflammasome